Blood Coagulation Factors
"Blood Coagulation Factors" is a descriptor in the National Library of Medicine's controlled vocabulary thesaurus,
MeSH (Medical Subject Headings). Descriptors are arranged in a hierarchical structure,
which enables searching at various levels of specificity.
Endogenous substances, usually proteins, that are involved in the blood coagulation process.
Descriptor ID |
D001779
|
MeSH Number(s) |
D12.776.124.125 D23.119
|
Concept/Terms |
Blood Coagulation Factors- Blood Coagulation Factors
- Blood Coagulation Factor
- Factor, Blood Coagulation
- Coagulation Factor, Blood
- Coagulation Factors, Blood
- Factors, Blood Coagulation
- Coagulation Factors
- Factor, Coagulation
- Factors, Coagulation
- Coagulation Factor
- Clotting Factors
- Factors, Clotting
|
Below are MeSH descriptors whose meaning is more general than "Blood Coagulation Factors".
Below are MeSH descriptors whose meaning is more specific than "Blood Coagulation Factors".
This graph shows the total number of publications written about "Blood Coagulation Factors" by people in this website by year, and whether "Blood Coagulation Factors" was a major or minor topic of these publications.
To see the data from this visualization as text,
click here.
Year | Major Topic | Minor Topic | Total |
---|
2001 | 1 | 0 | 1 |
2004 | 0 | 1 | 1 |
2005 | 0 | 1 | 1 |
2006 | 1 | 0 | 1 |
2010 | 1 | 0 | 1 |
2013 | 1 | 0 | 1 |
2014 | 0 | 1 | 1 |
2017 | 1 | 0 | 1 |
2018 | 1 | 0 | 1 |
2019 | 1 | 2 | 3 |
2020 | 2 | 0 | 2 |
2021 | 1 | 0 | 1 |
2022 | 0 | 1 | 1 |
2023 | 1 | 0 | 1 |
To return to the timeline,
click here.
Below are the most recent publications written about "Blood Coagulation Factors" by people in Profiles.
-
Prothrombin Complex Concentrate Should Be Used to Reverse Factor Xa Inhibitors in the Setting of Life-Threatening Bleeding. Ann Emerg Med. 2023 Sep; 82(3):362-363.
-
Clinical outcomes after 4F-PCC for warfarin-associated ICH and baseline GCS less than or equal to 8. Am J Emerg Med. 2022 09; 59:59-62.
-
Institution of prothrombin complex concentrate protocols is associated with a reduction in plasma administration at a Tertiary Care Hospital. J Clin Anesth. 2021 Jun; 70:110164.
-
Emergent Warfarin Reversal With Fixed-Dose 4-Factor Prothrombin Complex Concentrate. Ann Pharmacother. 2020 11; 54(11):1090-1095.
-
Factor Xa Inhibitor-Related Intracranial Hemorrhage: Results From a Multicenter, Observational Cohort Receiving Prothrombin Complex Concentrates. Circulation. 2020 05 26; 141(21):1681-1689.
-
Reversal of Warfarin-Associated Major Hemorrhage: Activated Prothrombin Complex Concentrate versus 4-Factor Prothrombin Complex Concentrate. Thromb Haemost. 2020 Feb; 120(2):207-215.
-
Evaluation and Management of Angioedema in the Emergency Department. West J Emerg Med. 2019 Jul; 20(4):587-600.
-
Mixing Studies in Patients With Prolonged Activated Partial Thromboplastin Time or Prothrombin Time. Anesth Analg. 2019 06; 128(6):1089-1096.
-
Clotting-Factor Concentrations 5 Days After Discontinuation of Warfarin. Reg Anesth Pain Med. 2018 Aug; 43(6):616-620.
-
Comparison of Fresh Frozen Plasma With Prothrombin Complex Concentrate for Warfarin Reversal. Ann Emerg Med. 2017 06; 69(6):777-779.